J Nicholson, B D O'Neill, P Thirion, M Cunningham, G McVey, J Coffey, A M Mihai, P J Kelly, N Elbeltagi, M Dunne, E Noone, I Parker, A M Shannon, M McCague, A Alvarez-Iglesias, H Kelly, R O'Donovan, D Hajdaraj, G Lawler, J G Armstrong
PURPOSE/OBJECTIVE(S): Published data supports the use of very high dose intensity modulated radiotherapy (IMRT) in achieving high efficacy and low toxicity for high-risk prostate cancer (HRPCa). This phase II multi-institutional non-randomized prospective dose escalation study using intensity modulated radiotherapy (IMRT) for high risk N0M0 prostate cancer was designed to investigate dose escalation using 1.8 Gy increments from baseline 75.6 Gy up to maximum 81 Gy, once dose volume constraints were adhered to...
October 1, 2023: International Journal of Radiation Oncology, Biology, Physics